PIC/S adopts guidance on PQS risk-based change management, COVID-19 risk assessments
Regulatory NewsJeff Craven
Audit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyEuropeGlobalNorth AmericaPharmaceuticalsRegulatory NewsJeff CravenAudit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyEuropeGlobalNorth AmericaPharmaceuticals